Clinical Experience With Venetoclax‐Based Combinations for Relapsed/Refractory or
MRD
‐Positive
NPM1
‐Mutated Acute Myeloid Leukemia
American Journal of Hematology | April 2, 2026 | Volume: 101 | Issue: 7 | Pages: 1451-1455
10.1002/ajh.70313
| PMID 41922102